Featured
Last news
Combs's ex Cassie returns to witness stand
Defense lawyers for Sean Combs have another stab Friday at the testimony of the music mogul's former girlfriend Casandra Ventura, who will return to the stand for a fourth day of marathon questioning in his sex trafficking trial.
Thai tycoon surrenders over deadly skyscraper collapse
A Thai construction tycoon turned himself in on Friday to face charges of alleged negligence over the collapse of a skyscraper that killed dozens of people in a powerful earthquake, police said.
Global acute hunger hits new high, 2025 outlook 'bleak': UN-backed report
More than 295 million people faced acute hunger last year, a new high driven by conflict along with other crises -- and the outlook is "bleak" for 2025 as humanitarian aid falters, a UN-backed report said Friday.
Salman Rushdie attacker faces sentencing
An American-Lebanese man will be sentenced on Friday for trying to kill novelist Salman Rushdie in a 2022 knife attack at a New York cultural center.
What's Up? Media Article on Menhaden Fails to Tell Both Sides
WASHINGTON, DC / ACCESS Newswire / May 16, 2025 / A recent article by Lisa Lewis in What's Up? Media ("The Osprey-Menhaden Bay Connection," 5/16) presents a one-sided perspective that echoes the claims of a well-funded coalition of special interest environmental groups, while ignoring the extensive scientific evidence and stakeholder voices that contradict their narrative. The piece amplifies talking points that have been challenged by federal agencies, independent scientists, and frontline workers in the industry, while repeating several inaccurate claims about the menhaden fishery.
Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
VANCOUVER, BC / ACCESS Newswire / May 16, 2025 / Onco-Innovations Limited (CSE:ONCO) ("Onco" or the "Company") is pleased to announce that it will transfer the listing of its common shares (the "Common Shares") to Cboe Canada Inc. ("Cboe Canada") from the Canadian Securities Exchange ("CSE"). Onco expects its Common Shares to begin trading on Cboe Canada on May 22, 2025 under its existing ticker symbol "ONCO", and the Company has submitted a request to voluntarily delist its Common Shares from the CSE, which is expected to take effect at the close of trading on May 21, 2025. No action is required from shareholders regarding this transition.
Havertys Announces Second Quarter Cash Dividend
ATLANTA, GA / ACCESS Newswire / May 16, 2025 / HAVERTY FURNITURE COMPANIES, INC. (NYSE:HVT and HVT.A) announced today that its Board of Directors declared a cash dividend to be paid on the outstanding shares of the two classes of $1 par value common stock of the company at a rate of $0.32 per share on the common stock and $0.30 per share on the Class A common stock. The dividend is payable on June 17, 2025, to stockholders of record at the close of business on June 2, 2025. Havertys has paid a cash dividend in each year since 1935.
Prevent-Plus Highlights Key PREVENTOGEN Infection Prevention Clinical Data Presented at the 44th Annual Surgical Infection Society Meeting
Prevent-Plus, a progressive leader in the management and prevention of surgical site infections, presented the results of two recent studies using Preventogen for the prevention of infections: after elective surgery and after the insertion of Tunneled Hemodialysis catheters.
MD&M East Partners with New York Robotics
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Informa Markets Engineering, the leading business to business (B2B) event producer, publisher and digital media platform for the advanced manufacturing industry, today announces its involvement as a founding partner for New York Robotics.
Wi2Wi Corporation Announces First Quarter 2025 Financial Results (Unaudited)
TORONTO, ON / ACCESS Newswire / May 16, 2025 / Wi2Wi Corporation (TSX-V:YTY)(OTC PINK:ISEYF) a leader in precision timing devices, frequency control products, and wireless technologies, today announced its financial results for the first quarter ended March 31, 2025.
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
Cash expected to fund operations into the second half of 2026Advancing development strategy for lead program TPI 287 to commence Phase 2 study around year end 2025 for treatment of glioblastoma multiforme (GBM)
CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results
BEIJING, CN / ACCESS Newswire / May 16, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the quarter ended March 31, 2025.
NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu
SHELTON, CT / ACCESS Newswire / May 16, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending March 31, 2025 with the Securities and Exchange Commission (SEC) on Thursday, May 15, 2025. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000141057825001336/nnvc-20250331x10q.htm) .
US cops investigating Smokey Robinson after sex assault lawsuit
Motown legend Smokey Robinson is under criminal investigation, law enforcement in Los Angeles said Thursday, just days after he was sued by four former housekeepers who allege the soul singer repeatedly raped and sexually assaulted them.
Real Madrid's Asencio wants 'presumption of innocence' in underage sex video case
Real Madrid defender Raul Asencio said Thursday a presumption of innocence "must continue to prevail" after he was indicted in a case involving the viewing and distribution of a sexual video involving a minor.
Cannes bars actor accused of rape in new #MeToo policy
The Cannes film festival barred an actor in a prominent French film from the red carpet on Thursday because of sexual assault allegations, unveiling a new policy under pressure from lawmakers and activists.
Slovenia probes disappearance of latest Melania Trump statue
The first Melania Trump statue in her native Slovenia was destroyed by fire and now its bronze replacement has gone missing, prompting a police investigation.
Rome businesses count their blessings with US pope
The election of the first US pope is a godsend to businesses in Rome, as big-spending pilgrims flocking to the Vatican are also expected to spend in the Eternal City.
'Unscientific' Japan megaquake rumours spook Hong Kong tourists
Unfounded online rumours warning that a huge earthquake will soon strike Japan are taking a toll on travel firms and airlines who report less demand from worried Hong Kongers.
South Korea police arrest two over Son Heung-min 'blackmail'
Two people have been arrested for allegedly blackmailing Spurs and South Korea captain Son Heung-min, police said Thursday.
Newsmax Announces First Quarter 2025 Financial Results
Company Reports Revenues of $45.3 million, an 11.6% Increase Year-Over-Year, In First Earnings Report as a Public CompanyNewsmax Remains the 4th Highest-Rated Cable News Channel With Over 33 Million Quarterly Viewers
WasteExpo 2025 Gathers more than 14,500 Registered Professionals to Unveil New Products and Solutions to Drive Efficiencies in Waste Management
This year's edition held 600+ exhibitors spanning 90 product categories, hosting critical conversations in technology & innovation, operations, fleet & safety, investment, upcycling and organics recycling.
Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
ANN ARBOR, MI / ACCESS Newswire / May 15, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2025.
Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
FORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2025 first quarter report on Form 10-Q on Thursday, May 15, 2025. The following are highlights of the report:
Envela Announces Dual Listing on NYSE Texas
IRVING, TX / ACCESS Newswire / May 15, 2025 / Envela Corporation today announced the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas. The Company will maintain its primary listing on the NYSE American and will trade under the same ticker symbol, ELA, on NYSE Texas.
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results
- Therapeutic DNA Production Services Segment (LineaRx) Revenues Up 44% Y/Y, Contributing to a 6% Increase in Total Revenues -- Intra-Quarter Investor Conference Call and Webcast Scheduled for June 3, 2025, at 4:30 PM ET -
TruMerit Hails Release of WHO's State of the World's Nursing Report
The report highlights a critical imperative to strengthen global nursing capacity in the wake of the pandemic and amid economic uncertainty, climate change impacts, and persistent health inequities. It warns that the global health workforce shortage will continue to widen, reaching 11 million by 2030, thereby requiring a fundamental shift in how countries approach healthcare workforce planning and investment.
A1 Group announces Acquisition of New Production Facility
COLTON, CA / ACCESS Newswire / May 15, 2025 / A1 Group, Inc. (OTC:AWON -- hereinafter referred to as the "Company"), through its wholly-owned subsidiary, AICPG, LLC, stands as a pioneering force at the intersection of technology and consumer product development, today announced the acquisition of a fully integrated beverage manufacturing facility in Toronto, Canada.
Jaguar Health Reports First Quarter 2025 Financials
The combined net Q1 2025 revenue of approximately $2.2 million for prescription and non-prescription products, including license revenue, decreased approximately 6% versus net Q1 2024 revenue of $2.4 million and 37% versus net Q4 2024 revenue of $3.5 million Mytesi prescription volume increased by approximately 1.8% in Q1 2025 over Q1 2024 and decreased by approximately 13.5% in Q1 2025 over Q4 2024REMINDER: Today Jaguar to host investor webcast at 4:15 p.m. Eastern regarding Q1 2025 financials and company updates; Click here to registerProof-of-concept (POC) results show crofelemer reduced total parenteral nutrition in patients with rare orphan diseases microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) by up to 27% and 12.5% - potential to modify disease progression in intestinal failure patients; Click here to access replay of April 30, 2025 investor webcast about results; additional POC results expected throughout 2025 for MVID and SBS-IFFDA meeting in Q2 2025 on statistically significant results of Phase 3 OnTarget trial of crofelemer in prespecified subgroup of patients with breast cancer
AGS Health Expands into Mexico with Guadalajara Location Offering Clinical Administrative Services
WASHINGTON, DC / ACCESS Newswire / May 15, 2025 / AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., announced today its expansion into Mexico with the opening of an office in Guadalajara. Taking advantage of the region's growing technology presence and a skilled medical, legal, and engineering workforce, AGS Health will hire more than 150 team members to provide Clinical Administrative Services from the new location.
New to The Street(R) Signs Skip Barber Racing School to Upgraded 12-Part National Broadcast and Media Partnership
The Closest Thing to Royalty in American Car Racing
Interactive Strength Inc. (Nasdaq:TRNR) Shares Update from CEO Q&A Featuring Both TRNR and Sportstech CEO's
Top-to-Top Conversation Offers Transparency and ConfidenceAhead of Q1 Earnings Report